Poland· PL-100087340
Betnovate N
A betamethason und antibiotika product containing betamethasoni valeras + neomycini sulfas, registered in Poland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Betamethason und antibiotika is registered in 9 of 19 countries.
Countries holding a registration under ATC D07CC01 (betamethason und antibiotika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Betamethason und antibiotika · ATC D07CC01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Betamethasoni valeras + Neomycini sulfas
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Poland (PL)
- ATC code
- D07CC01
- ATC class
- Betamethason und Antibiotika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990423514
- gtin05909990423521
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D07CC01
Betamethason und antibiotika, as other registers publish it.
- BelgiumAcide Fusidique/Bétaméthasone Valérate Goapharma 20 mg/g - 1 mg/gGoapharma
- FinlandAddicortStrides Nordic ApS
- BelgiumAtosene 20 mg/g - 1 mg/gLaboratoires Medgen
- PolandBedicort GBausch Health Ireland Ltd.
- PolandBedicort GPharmapoint SA
- PolandBedicort GInPharm Sp. z o.o.
- PolandBelodermBelupo s.r.o.
- PolandBelodermBelupo s.r.o.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Austria · Betnesol
- United Kingdom (Northern Ireland) · Betamethasone Valerate/Neomycin Sulfate Chemidex Pharma, Betamethasone Valerate/Neomycin Sulphate Chemidex Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/774aa6e9-1abf-41c9-8f8f-3dcc759046e9 GET /v1/drugs/774aa6e9-1abf-41c9-8f8f-3dcc759046e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(1,22 mg + 5 mg)/g",
"packaging": "05909990423514 ¦ Rp ¦ 13512\n1 tuba 15 g\n05909990423521 ¦ Rp ¦ 13513\n1 tuba 30 g",
"substance": "Betamethasoni valeras 1.22 mg/g + Neomycini sulfas 5 mg/g",
"common_name": "Betamethasoni valeras + Neomycini sulfas",
"pl_product_id": "100087340",
"pozwolenie_nr": "04235",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about betamethason und antibiotika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.